Lung (Pulmonary) Function Tests for Asthma Diagnosis

Asthma can be a master of disguise. One day it’s a wheeze, the next day it’s a cough that “totally isn’t a cold,” and the day after that it’s chest tightness
that shows up precisely when you’re late for something important. Because symptoms can overlap with other conditions, clinicians lean on lung (pulmonary)
function tests to get objective proof of what’s happening inside the airwayshow much air moves, how fast it moves, and whether the airflow limitation is
variable (a big asthma clue).

This article breaks down the tests most commonly used to diagnose asthmaespecially spirometry and bronchodilator reversibilityplus add-on tools like FeNO
and bronchoprovocation testing when spirometry doesn’t tell the whole story. You’ll also see practical examples of what results can look like, what they mean,
and what questions to ask so you leave the appointment with clarity instead of a mysterious printout and a shrug.

Why lung function tests matter for asthma (and not just “because your doctor said so”)

Asthma is typically defined by two big ideas: (1) respiratory symptoms that come and go (wheezing, shortness of breath, chest tightness, cough), and (2)
variable airflow limitationairways narrow, then improve, often with medication or as triggers fade. Lung function tests help document that narrowing and
improvement. In many people age 5 and older, spirometry is the main objective test used to support an asthma diagnosis.

Just as important: lung testing helps avoid mislabeling. A surprising number of people carry an asthma diagnosis without objective confirmation, and others
may have asthma but get missed because symptoms are intermittent. Testing adds reality-check data to the conversation: “Is there obstruction?” “Does it reverse?”
“Do we need to provoke the airways to reveal the pattern?”

Spirometry: the headline act

What spirometry measures (in plain English)

Spirometry measures airflow during a forceful exhale. The star numbers include:

• FEV1: how much air you blow out in the first second (speed + openness of airways).
• FVC: the total amount of air you can blow out after a full inhale (volume).
• FEV1/FVC ratio: a key marker of obstruction; a lower-than-expected ratio suggests narrowed airways.

In asthma, spirometry may show obstruction (often a reduced FEV1/FVC ratio) that improves after a bronchodilator. But here’s a crucial twist: spirometry
can look normal between flare-ups. A “normal” test doesn’t automatically mean “no asthma,” especially if symptoms strongly suggest it.

What the test is like

You’ll sit upright, seal your lips around a mouthpiece, take the biggest breath you can, then blast air out hard and fast until you’re truly empty.
It’s a short athletic event that rewards effort and technique. You’ll repeat it multiple times because the machine is picky (in a good way):
it needs consistent blows to trust the numbers.

Many people feel a little lightheaded from repeated forceful breathing. That’s common, and the staff will pace you and coach youthink of them as your
exhale cheerleaders with a clipboard.

A realistic example of spirometry results

Imagine a 22-year-old with intermittent wheezing:

• Before medication: FEV1 = 2.60 L (about 78% predicted), FVC = 3.80 L, FEV1/FVC = 0.68
• After albuterol: FEV1 = 3.05 L (about 91% predicted), FEV1/FVC = 0.76

That jump in FEV1 (0.45 L) and improved ratio suggests reversible airflow limitation. In real clinics, clinicians interpret this alongside symptoms and history.
If the story fitsand the numbers improve meaningfullyspirometry can strongly support an asthma diagnosis.

Bronchodilator reversibility testing: the “before and after” that asthma likes to show off

How it works

Reversibility testing is typically spirometry performed before and after an inhaled bronchodilator (often albuterol). If the airways open
up significantly after the medication, that supports asthma because it demonstrates variable airflow limitation.

What counts as a significant response?

You’ll often hear the classic threshold: an increase in FEV1 (or FVC) of at least 12% and at least 200 mL
from baseline. That’s a long-used clinical benchmark and still widely referenced. Newer interpretive strategies in professional standards may also discuss
changes relative to predicted values (to better account for body size and baseline lung function). Translation: your clinician may describe “significant”
improvement a little differently depending on the lab’s reporting and the guideline framework they follow.

What if the bronchodilator response is “negative”?

A lack of clear reversibility does not automatically rule out asthma. Reasons include:

• Timing: you may not be symptomatic during the test (asthma can be episodic).
• Medication effects: controller therapy (like inhaled corticosteroids) can reduce variability.
• Different pattern: some people have asthma with less dramatic day-to-day reversibility on spirometry.
• Technique: if the blow isn’t maximal or consistent, the “after” might not reflect true potential improvement.

When suspicion remains high, clinicians often move to additional testingespecially bronchoprovocation (challenge) tests designed to reveal airway
hyperresponsiveness.

When spirometry is normal: challenge tests that “poke the bear” (safely)

If symptoms suggest asthma but baseline spirometry looks normal, clinicians may use bronchoprovocation testing. These tests intentionally expose the airways
to a trigger under controlled conditions and measure whether airflow drops in a way that suggests asthma-like hyperreactivity.

Methacholine challenge test

Methacholine is an inhaled substance that can cause airway narrowing in susceptible people. During the test, you inhale increasing doses, and spirometry is
repeated after each step. A meaningful drop in lung functioncommonly defined as a 20% fall in FEV1 at a relatively low dosesupports
airway hyperresponsiveness consistent with asthma.

Clinically, methacholine challenge is often valued for its ability to help rule out asthma when results are negative and pretest probability is
moderate. Your clinician will still interpret results in context because other conditions (and even recent respiratory infections) can influence responsiveness.

Exercise challenge (and cousins like eucapnic hyperventilation)

If symptoms mainly occur with activitycough, tightness, wheeze during or after workoutsan exercise challenge may be used. The idea is simple:
measure baseline spirometry, stress the system (treadmill/bike or controlled hyperventilation), then measure again. A post-exercise drop in FEV1 can support
exercise-induced bronchoconstriction, which often overlaps with asthma.

These tests can be particularly helpful when a person’s day-to-day spirometry is normal, but their lungs “complain loudly” only after exertion.

Other provocation options (used selectively)

Some centers use alternative triggers such as inhaled mannitol. The exact menu depends on the lab, local expertise, and the clinical question. Regardless of
the trigger, the goal is the same: objectively document variable airway narrowing.

FeNO: a breath test for inflammation clues (not a standalone diagnosis)

What FeNO measures

Fractional exhaled nitric oxide (FeNO) measures nitric oxide in exhaled air, which can reflect eosinophilic (Type 2) airway inflammationoften associated
with allergic asthma and steroid responsiveness. It’s fast and noninvasive: you exhale steadily into a device, and it reports a number (usually in ppb).

How clinicians use FeNO in real life

FeNO is generally an adjunct test. It can support asthma evaluation when the story is suggestive, help identify an inflammatory phenotype, and
assist with treatment decisions (like whether inhaled corticosteroids are likely to help, or whether inflammation is still active despite feeling “okay”).

Many clinicians reference interpretive cut points (commonly discussed in professional guidance), such as:

• Adults: lower FeNO (often <25 ppb) makes eosinophilic inflammation less likely; higher (often >50 ppb) makes it more likely.
• Children: lower (often <20 ppb) vs higher (often >35 ppb) cut points are commonly discussed.

FeNO can be influenced by factors like smoking, recent infections, allergy season, and current steroid use. That’s why it’s rarely used as the first and only
test for diagnosis; it’s better as one piece of a larger puzzle.

Peak flow: useful for tracking, limited for diagnosing

Peak expiratory flow (peak flow) is measured with a small handheld meter that estimates how quickly you can blow air out. It’s cheap, portable, and can be
helpful for monitoring patterns at homeespecially variability over days and weeks.

But peak flow has limits: it’s effort-dependent, less precise than spirometry, and generally not considered sufficient by itself to diagnose asthma. Still, for
certain situations (like suspected work-related asthma), serial measurements can help document changes related to exposuresespecially when done carefully and
interpreted by a clinician.

Full pulmonary function tests (PFTs): lung volumes and diffusion when the question gets bigger

Spirometry is often the core asthma test, but “pulmonary function testing” can include more:

• Lung volumes: evaluate how much air is in the lungs at different points (can detect air trapping or restriction).
• DLCO (diffusing capacity): estimates how well gases move from the air sacs into the blood.

These expanded tests are not required for every asthma evaluation, but they’re helpful when symptoms are complex, when another lung condition is possible,
or when clinicians want to better characterize physiology (for example, distinguishing asthma from restriction, or evaluating shortness of breath that doesn’t
match spirometry findings).

Preparing for testing: small steps that protect your results

Good test prep improves accuracy. The lab will tell you exactly what to do, but common recommendations include:

• Medication instructions: you may be asked to hold certain inhalers for a specific period before the test (timing depends on the medication and the test type).
• Skip heavy meals right before: a very full stomach can make deep breathing uncomfortable.
• Avoid smoking or vaping before testing (if applicable): it can alter airway tone and measurements.
• Wear comfortable clothing: you want your chest and abdomen to expand freely.

If you’re sick with a respiratory infection, tell the labtesting may still happen, but interpretation can change because infections can temporarily affect
airway responsiveness and inflammation.

Common pitfalls (and how clinicians think about them)

Technique can make or break spirometry

Spirometry is a performance test. If someone doesn’t inhale fully, leaks air around the mouthpiece, or stops exhaling early, values can look falsely low.
That’s why you’ll hear a lot of coaching“Bigger breath!” “Blast it!” “Keep going, keep going!” It’s not drama; it’s quality control.

Asthma isn’t the only cause of wheeze or shortness of breath

Clinicians interpret PFTs alongside the history and exam because several conditions can mimic asthma:

• Vocal cord dysfunction / inducible laryngeal obstruction: can cause inspiratory symptoms and “asthma-like” episodes, often with normal spirometry.
• COPD: also causes obstruction, typically with less reversibility and a different risk profile.
• Heart conditions, anemia, deconditioning: can cause breathlessness without classic obstructive patterns.
• Chronic sinus/postnasal drip or reflux: can drive cough that looks like asthma.

The point isn’t to make the diagnosis feel complicatedit’s to make it accurate. Accurate diagnosis leads to targeted treatment instead of “let’s try three
inhalers and hope for the best.”

What to ask after you get results

• Do my results show obstruction? If yes, what’s the evidence (FEV1/FVC, flow-volume loop, etc.)?
• Was there significant bronchodilator reversibility? How was “significant” defined by this lab?
• If spirometry is normal, what’s next? Would a challenge test or FeNO help clarify?
• How do my results match my symptoms? Are there triggers or patterns that suggest asthma vs another cause?
• What should we re-test and when? Especially after starting or adjusting controller therapy.

Experiences with lung function testing for asthma diagnosis (real-world, human stuff)

People often walk into pulmonary function testing with two competing thoughts: “This seems simple” and “What if I mess it up?” The good news is that the
process is designed for normal humansnot professional trumpet players. Many patients say the most surprising part is how much coaching happens. The staff
will often demonstrate the maneuver, correct posture, and talk you through each attempt. It can feel a little like a mini sports tryout: you’ll do multiple
blows, rest briefly, then repeat until the results are consistent. If you’re worried you “did it wrong,” that’s exactly why repetition is built in.

A common sensation during spirometry is lightheadedness. That doesn’t mean anything scary is happening; it usually comes from repeated forceful exhalations
and rapid breathing patterns. Patients frequently report that taking a few slow breaths between efforts helps. Some people also notice coughing after a big
blowespecially if cough is part of their symptom pattern. Labs expect that, and they’ll pause if you need a break. If you have chest pain, feel faint, or
have a medical condition that makes straining risky, it’s important to tell the staff up front so they can adjust the approach or confirm it’s safe to proceed.

The bronchodilator portion can be emotionally reassuring for some people: they feel the medication “kick in” and suddenly realize what easier breathing feels
like. Others feel nothing obviousand that can be confusing. A key real-world takeaway clinicians often emphasize is that asthma doesn’t always announce itself
on demand. If you’re having a good lung day, the numbers may look close to normal. That doesn’t make your symptoms imaginary; it just means the test captured
a calmer moment. In those cases, people often describe feeling validated when clinicians explain the “next step” options (challenge testing, FeNO, or repeating
spirometry later) rather than acting as if the normal result ends the conversation.

For methacholine or exercise challenge tests, patients commonly describe a different kind of nervousness: “Are you going to trigger my symptoms on purpose?”
The experience is usually more controlled than people expect. You’re monitored, spirometry is repeated frequently, and the test is designed to stop as soon as
there’s a significant response or you reach the planned endpoint. Many patients say the most noticeable feelingif they reactis chest tightness or increased
work of breathing, similar to their usual episodes, followed by relief after a bronchodilator is given. People also report that knowing the “why” helps: the
goal isn’t to make anyone miserable; it’s to document a pattern that guides treatment decisions with more confidence.

FeNO testing tends to be the least intimidating experience: it’s typically a steady, controlled exhale into a device. Patients often like that it produces a
simple number that can be tracked over time, especially for allergic or eosinophilic asthma patterns. Still, it can be frustrating if the number doesn’t match
how you feelanother reason clinicians frame FeNO as one data point rather than the final verdict. Overall, people who have the smoothest testing experience
usually share the same strategy: ask what the lab wants (how hard, how long, how many times), follow the coaching like a recipe, and don’t worry about being
perfect on the first attempt. The equipment and staff are there to help you produce a result that reflects your lungsnot your anxiety.

Conclusion

Lung (pulmonary) function tests take asthma diagnosis from “sounds like it” to “here’s what your airways are doing.” Spirometry is the cornerstone for many
patients age 5 and older, especially when paired with bronchodilator reversibility testing to show variable airflow limitation. When spirometry is normal but
symptoms persist, challenge tests (like methacholine or exercise testing) can reveal airway hyperresponsiveness. FeNO adds a different lensairway inflammation
that can support phenotype and treatment decisions, while peak flow can help track patterns over time.

If you remember one thing: results are most powerful when interpreted alongside your story. Bring your symptom patterns, triggers, and questions to the table,
and let the testing provide the objective backup that helps you and your clinician choose the right next step.